Infarcts Due to Large Vessel Occlusions Continue to Grow Despite Near-Complete Reperfusion After Endovascular Treatment.

Autor: Ospel JM; Department of Radiology, University of Calgary, Calgary, AB, Canada.; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada., Rex N; Department of Radiology, University of Calgary, Calgary, AB, Canada.; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., Oueidat K; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., McDonough R; Department of Radiology, University of Calgary, Calgary, AB, Canada., Rinkel L; Department of Radiology, University of Calgary, Calgary, AB, Canada., Baird G; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., Collins S; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., Jindal G; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., Alvin MD; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., Boxerman J; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., Barber P; Department of Radiology, University of Calgary, Calgary, AB, Canada., Jayaraman M; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., Smith W; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., Amirault-Capuano A; Department of Diagnostic Imaging, Brown University, Providence, RI, USA., Hill MD; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada., Goyal M; Department of Radiology, University of Calgary, Calgary, AB, Canada., McTaggart R; Department of Diagnostic Imaging, Brown University, Providence, RI, USA.

Publikováno v: Journal of stroke [J Stroke] 2024 May; Vol. 26 (2), pp. 260-268. Date of Electronic Publication: 2024 May 30.

Pearls & Oy-sters: Adult-Onset Craniopharyngioma Presenting With Cognitive Dysfunction and Obstructive Hydrocephalus.

Autor: Schroeder LE; From Brown University, Providence, RI. 89schroeder@gmail.com., Kritselis M; From Brown University, Providence, RI., Lala N; From Brown University, Providence, RI., Boxerman J; From Brown University, Providence, RI., Alhusaini S; From Brown University, Providence, RI.

Publikováno v: Neurology [Neurology] 2023 Nov 21; Vol. 101 (21), pp. 974-978. Date of Electronic Publication: 2023 Oct 03.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.

Autor: Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Gerstner ER; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lassman AB; Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, New York, USA., Chung C; University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Cole PE; Bayer Pharmaceuticals, Whippany, New Jersey, USA., Leung D; Bristol Myers Squibb, Princeton, New Jersey, USA., Allen JE; Chimerix, Durham, North California, USA., Ahluwalia MS; Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, USA., Boxerman J; Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, USA., Brown M; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Goldin J; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Nduom E; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA., Hassan I; Servier Pharmaceuticals, Boston, Massachusetts, USA., Gilbert MR; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA., Mellinghoff IK; Department of Neurology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Weller M; Department of Neurology, University Hospital and University of Zurich, Switzerland., Chang S; Division of Neuro-Oncology, University of California San Francisco, San Francisco, California, USA., Arons D; National Brain Tumor Society, Newton, Massachusetts, USA., Meehan C; National Brain Tumor Society, Newton, Massachusetts, USA., Selig W; WSCollaborative, LLC, McLean, Virginia, USA., Tanner K; National Brain Tumor Society, Newton, Massachusetts, USA., Alfred Yung WK; University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Wen PY; Dana Farber Cancer Institute, Harvard University, Boston, Massachusetts, USA., Cloughesy TF; UCLA Neuro Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2022 Aug 01; Vol. 24 (8), pp. 1219-1229.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.